4.6 Article

Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection

期刊

PLOS COMPUTATIONAL BIOLOGY
卷 12, 期 5, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pcbi.1004940

关键词

-

资金

  1. HIVRAD NIH grant [P01-AI104722]
  2. Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases
  3. National Human Genome Research Institute, National Institutes of Health
  4. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes for Health (NIH), U.S. Department of Health and Human Services

向作者/读者索取更多资源

Accumulation of somatic mutations in antibody variable regions is critical for antibody affinity maturation, with HIV-1 broadly neutralizing antibodies (bnAbs) generally requiring years to develop. We recently found that the rate at which mutations accumulate decreases over time, but the mechanism governing this slowing is unclear. In this study, we investigated whether natural selection and/or mutability of the antibody variable region contributed significantly to observed decrease in rate. We used longitudinally sampled sequences of immunoglobulin transcripts of single lineages from each of 3 donors, as determined by next generation sequencing. We estimated the evolutionary rates of the complementarity determining regions (CDRs), which are most significant for functional selection, and found they evolved about 1.5- to 2-fold faster than the framework regions. We also analyzed the presence of AID hotspots and coldspots at different points in lineage development and observed an average decrease in mutability of less than 10 percent over time. Altogether, the correlation between Darwinian selection strength and evolutionary rate trended toward significance, especially for CDRs, but cannot fully explain the observed changes in evolutionary rate. The mutability modulated by AID hotspots and coldspots changes correlated only weakly with evolutionary rates. The combined effects of Darwinian selection and mutability contribute substantially to, but do not fully explain, evolutionary rate change for HIV-1-targeting bnAb lineages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu, Sho Iketani, Yicheng Guo, Jasper F-W Chan, Maple Wang, Liyuan Liu, Yang Luo, Hin Chu, Yiming Huang, Manoj S. Nair, Jian Yu, Kenn K-H Chik, Terrence T-T Yuen, Chaemin Yoon, Kelvin K-W To, Honglin Chen, Michael T. Yin, Magdalena E. Sobieszczyk, Yaoxing Huang, Harris H. Wang, Zizhang Sheng, Kwok-Yung Yuen, David D. Ho

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

Article Multidisciplinary Sciences

Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines

Svenja Weiss, Vincenza Itri, Ruimin Pan, Xunqing Jiang, Christina C. Luo, Lynn Morris, Delphine C. Malherbe, Philip Barnette, Jeff Alexander, Xiang-Peng Kong, Nancy L. Haigwood, Ann J. Hessell, Ralf Duerr, Susan Zolla-Pazner

Summary: The authors demonstrate that an HIV vaccine targeting the V1V2 region of gp120 is superior to whole envelope vaccines or natural infection in inducing V1V2 antibodies with anti-viral functions that correlate with protection.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Cryo-EM structure of the SARS-CoV-2 Omicron spike

Gabriele Cerutti, Yicheng Guo, Lihong Liu, Liyuan Liu, Zhening Zhang, Yang Luo, Yiming Huang, Harris H. Wang, David D. Ho, Zizhang Sheng, Lawrence Shapiro

Summary: The Omicron variant of SARS-CoV-2, known for its high ability to evade neutralizing antibodies, has been found to have 34 mutations in the spike protein, with 15 of them occurring in the receptor-binding domain (RBD). A cryo-EM structure of the Omicron spike protein reveals that it is exclusively in the 1-RBD-up conformation, with high mobility of RBD. These mutations in the spike protein cause steric clashes and altered interactions at antibody-binding surfaces, as well as changes in local regions that interfere with antibody recognition.

CELL REPORTS (2022)

Article Immunology

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses

Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper F-W Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu, Zizhang Sheng, Zhiwei Chen, Kwok-Yung Yuen, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro, David D. Ho

Summary: The development of potent and broad-spectrum antiviral therapeutics and vaccines is crucial in dealing with highly pathogenic human coronaviruses and their evolving variants. Monoclonal antibody 2-36, isolated from COVID-19-convalescent patients, has been found to cross-neutralize SARS-CoV and other coronaviruses. The cryo-EM structure of 2-36 with SARS-CoV-2 and SARS-CoV spike reveals a conserved epitope in the receptor-binding domain (RBD). This antibody can neutralize various SARS-CoV-2 variants, as well as bat and pangolin sarbecoviruses that use human ACE2 as a receptor.

EMERGING MICROBES & INFECTIONS (2022)

Article Immunology

Structural Basis of Antibody Conformation and Stability Modulation by Framework Somatic Hypermutation

Zizhang Sheng, Jude S. Bimela, Phinikoula S. Katsamba, Saurabh D. Patel, Yicheng Guo, Haiqing Zhao, Youzhong Guo, Peter D. Kwong, Lawrence Shapiro

Summary: This study used molecular dynamics simulation and data mining to investigate the effects of individual and combination somatic hypermutations (SHMs) on antibody conformation, flexibility, stability, and affinity. The researchers identified a common mechanism of modulation of heavy-light pairing orientation through disruption of a conserved hydrogen-bond network. They also observed remote epistasis between certain SHMs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Virology

Development and characterization of an inducible assay system to measure Zika virus capsid interactions

Jieshi Yu, Chen Huang, Zhao Wang, Radhey S. Kaushik, Zizhang Sheng, Feng Li, Dan Wang

Summary: In this study, a method to measure and identify the interaction of ZIKV capsid proteins was developed, and peptides that can inhibit the multimerization of ZIKV capsid were identified. This study is of great importance for the future discovery of ZIKV assembly inhibitors.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Multidisciplinary Sciences

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Qian Wang, Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri, Maple Wang, Jian Yu, Anthony D. Bowen, Jennifer Y. Chang, Jayesh G. Shah, Nadia Nguyen, Zhiwei Chen, Kathrine Meyers, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D. Ho

Summary: SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 have become dominant in the United States and South Africa, raising concerns about their ability to evade neutralizing antibodies and compromise the efficacy of COVID-19 vaccines and therapeutic monoclonals. A systematic antigenic analysis reveals that BA.2.12.1 and BA.4/5 have different levels of resistance to antibodies, with BA.2.12.1 being modestly resistant and BA.4/5 being substantially resistant. Certain mutations in the spike protein facilitate antibody escape, but compromise the spike affinity for the viral receptor. Only bebtelovimab retains full potency against both subvariants.

NATURE (2022)

Article Microbiology

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75

Qian Wang, Sho Iketani, Zhiteng Li, Yicheng Guo, Andre Yanchen Yeh, Michael Liu, Jian Yu, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D. Ho

Summary: The newly emerged SARS-CoV-2 Omicron subvariant BA.2.75 exhibits moderate resistance to neutralization by sera from vaccinated/boosted individuals compared to the currently circulating BA.2, but is more sensitive than BA.4/5. BA.2.75 shows heightened resistance to class 1 and class 3 monoclonal antibodies targeting the spike-receptor-binding domain, while gaining sensitivity to class 2 antibodies. The resistance is mainly conferred by two mutations. BA.2.75 also shows slight resistance to a therapeutic antibody with potent activity against all Omicron subvariants. Additionally, BA.2.75 exhibits higher binding affinity to the host receptor ACE2 compared to other Omicron subvariants.

CELL HOST & MICROBE (2022)

Letter Infectious Diseases

Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation

Qian Wang, Zhiteng Li, Jerren Ho, Yicheng Guo, Andre Yanchen Yeh, Hiroshi Mohri, Michael Liu, Maple Wang, Jian Yu, Jayesh G. Shah, Jennifer Y. Chang, Favio Herbas, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Lihong Liu, David Ho

LANCET INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Qian Wang, Sho Lekthan, Zhiten Li, Liyua Liu, Yichen Guo, Yiming Huang, Anthony D. Bowen, Michael Liu, Maple Wang, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Harris H. Wang, Aubree Gordon, Lihong Liu, David D. Ho

Summary: The BQ and XBB subvariants of SARS-CoV-2 Omicron, with additional spike mutations, are rapidly expanding and have altered antibody evasion properties. Neutralization of BQ.1, BQ.1.1, XBB, and XBB.1 by vaccinated individuals and infected persons' sera was significantly impaired, including those boosted with a WA1/BA.5 bivalent mRNA vaccine. The titers against BQ and XBB subvariants were much lower than observed before, indicating that these subvariants pose a serious threat to current COVID-19 vaccines and render all authorized antibodies inactive.
Article Multidisciplinary Sciences

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

Sho Iketani, Hiroshi Mohri, Bruce Culbertson, Seo Jung Hong, Yinkai Duan, Maria Luck, Medini K. Annavajhala, Yicheng Guo, Zizhang Sheng, Anne-Catrin Uhlemann, Stephen P. Goff, Yosef Sabo, Haitao Yang, Alejandro Chavez, David D. Ho

Summary: Nirmatrelvir, an experimental oral antiviral, has shown clinical usefulness against COVID-19. However, there is concern that SARS-CoV-2 could develop resistance to this drug. In vitro studies have demonstrated that highly resistant viruses can emerge from SARS-CoV-2 when exposed to Nirmatrelvir, with mutations in the 3CL protease. These findings provide insights into the mechanisms of resistance and can inform the development of next-generation protease inhibitors.

NATURE (2023)

Article Multidisciplinary Sciences

Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5

Khadidiatou Mangou, Adam J. Moore, Laty Gaye Thiam, Aboubacar Ba, Alessandra Orfano, Ife Desamours, Duncan Ndungu Ndegwa, Justin Goodwin, Yicheng Guo, Zizhang Sheng, Saurabh D. Patel, Fatoumata Diallo, Seynabou D. Sene, Mariama N. Pouye, Awa Thioub Faye, Alassane Thiam, Vanessa Nunez, Cheikh Tidiane Diagne, Bacary Djilocalisse Sadio, Lawrence Shapiro, Ousmane Faye, Alassane Mbengue, Amy K. Bei

Summary: The lack of progress in reducing global malaria deaths highlights the need for a highly effective vaccine. One major challenge in vaccine development is the diverse nature of Plasmodium falciparum antigens, which has been overlooked in previous evaluations. This study uses genomic approaches to evaluate the genetic diversity of the malaria vaccine candidate PfRh5 and identifies novel single nucleotide polymorphisms (SNPs) in the gene. The findings demonstrate that PfRh5 exhibits greater genetic diversity than previously described, with the potential for functional implications on immune evasion and receptor binding. These findings support continued efforts in validating PfRh5 as an effective malaria vaccine target and developing a PfRh5 vaccine.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Structures of LRP2 reveal a molecular machine for endocytosis

Andrew Beenken, Gabriele Cerutti, Julia Brasch, Yicheng Guo, Zizhang Sheng, Hediye Erdjument-Bromage, Zainab Aziz, Shelief Y. Robbins-Juarez, Estefania Y. Chavez, Goran Ahlsen, Phinikoula S. Katsamba, Thomas A. Neubert, Anthony W. P. Fitzpatrick, Jonathan Barasch, Lawrence Shapiro

Summary: In this study, high-resolution cryoelectron microscopy structures of LRP2 were analyzed, revealing that LRP2 is a molecular machine capable of binding ligands at the cell surface and releasing them in the endosome. LRP2 forms a homodimer and its conformational transformation is regulated by pH-sensitive sites. Deleterious missense variants of LRP2 appear to impair homodimer assembly. These observations provide insights into the function and mechanism of LDL receptors and suggest that homodimerization is a conserved feature of the LRP receptor subfamily.
Article Infectious Diseases

Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants

Lihong Liu, Kathrine Meyers, Lawrence J. Purpura, Nadia Nguyen, Hiroshi Mohri, Jennifer Y. Chang, Medini K. Annavajhala, Leo Lopez, Sang Won Lee, Jayesh Shah, Benjamin Lane, Anyelina Cantos, Sade A. Tukuru, Yicheng Guo, Kenra Ford, Yueh-Ting Chiu, Zizhang Sheng, Tenzin Choesang, Delivette Castor, Maple Wang, Christina Pili, Michael N. Van Hoy, Andrew Wallach, Jamie Horton, Zhiqiang Chen, Susan Rosenthal, Son McLaren, Baowei Jiang, Frank Wang, Helen H. Lu, Anne-Catrin Uhlemann, David D. Ho, Michael T. Yin

Summary: The development of a rapid antigen test using two pairs of monoclonal antibodies has resulted in a high-performing test that remains effective across multiple variants in both laboratory and clinical evaluations. The test is capable of identifying almost all individuals carrying infectious SARS-CoV-2.

JOURNAL OF CLINICAL VIROLOGY PLUS (2022)

Article Multidisciplinary Sciences

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Sho Iketani, Lihong Liu, Yicheng Guo, Liyuan Liu, Jasper F-W Chan, Yiming Huang, Maple Wang, Yang Luo, Jian Yu, Hin Chu, Kenn K-H Chik, Terrence T-T Yuent, Michael T. Yin, Magdalena E. Sobieszczyk, Yaoxing Huang, Kwok-Yung Yuen, Harris H. Wang, Zizhang Sheng, David D. Ho

Summary: The identification of the Omicron variant of SARS-CoV-2 in Botswana in November 2021 sparked concern due to the spike protein alterations that could potentially evade antibodies. Further studies showed that the Omicron sublineages, BA.1+R346K and BA.2, are antigenically similar to the wild-type virus and pose similar risks to the effectiveness of current vaccines. BA.2 also demonstrated resistance to many neutralizing monoclonal antibodies, highlighting the challenges in developing effective therapeutic options.

NATURE (2022)

暂无数据